日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The protocol for a patient-driven online prospective European observational cohort aiming to determine risk factors for the development of psoriatic arthritis among people living with psoriasis: the HIPPOCRATES Prospective Observational Study

一项由患者主导的、旨在确定银屑病患者发生银屑病关节炎风险因素的欧洲在线前瞻性观察队列研究方案:希波克拉底前瞻性观察研究

Grohmann, Teresa; Mtenga, Timeo; Kerr, David; Barrett, Joe; Gray, Nathanael; Bertheussen, Heidi; Cañete, Juan D; de Vlam, Kurt; de Wit, Maarten; Dimitroulas, Theodoros; Groothuizen, Sam; Haugeberg, Glenn; Hoff, Mari; Horváth, Rudolf; Hurnakova, Jana; Koehm, Michaela; Kotyla, Przemyslaw; Letarouilly, Jean-Guillaume; Lories, Rik; Løset, Mari; Möser, Christine; Möller, Burkhard; Mytilinaiou, Maria; Østergaard, Mikkel; Rodrigues, Ana; Ryan, Caitriona; Selmi, Carlo; Eidsmo, Liv; Svedbom, Axel; Torres, Tiago; Vreju, Florentin Ananu; van de Sande, Marleen G H; Werner, Lars; Pennington, Stephen R; FitzGerald, Oliver; Coates, Laura C

Skin Inflammation, Systemic Inflammation, and Cardiovascular Disease in Psoriasis

银屑病中的皮肤炎症、全身炎症和心血管疾病

Svedbom, Axel; Mallbris, Lotus; González-Cantero, Álvaro; Playford, Martin; Wu, Colin; Mehta, Nehal N; Ståhle, Mona

Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce

参与特应性湿疹治疗(TREAT)注册工作组的七个欧洲注册机构中登记的特应性湿疹患者的基线特征

Musters, A H; Gerbens, L A A; van der Gang, L; Middelkamp-Hup, M A; Ouwerkerk, W; Hijnen, D J; Haufe, E; Heinrich, L; Werfel, T; Weidinger, S; Schmitt, J; Svedbom, A; Johansson, E K; Bradley, M; von Kobyletzki, L B; Vittrup, I; Ruge, I F; Thyssen, J P; Vestergaard, C; Carrascosa, J M; de Vega, M; García-Doval, I; Chiricozzi, A; Stingeni, L; Calzavara-Pinton, P; Ardern-Jones, M R; Reynolds, N J; Flohr, C; Spuls, P I

Drug Survival and Predictors of Systemic Treatment Outcome in Atopic Dermatitis: Data From a Nationwide Swedish Cohort

特应性皮炎药物生存率及系统治疗结果预测因素:来自瑞典全国队列的数据

Jonsson, Pontus O; Tayefi, Mahsa; Svedbom, Axel; Bradley, Maria; Johansson, Emma K

Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian Cancer

肿瘤间质比例预测卵巢癌患者的化疗耐药性

Lou, Emil; Clemente, Valentino; Grube, Marcel; Svedbom, Axel; Nelson, Andrew C; Blome, Freya; Staebler, Annette; Kommoss, Stefan; Bazzaro, Martina

Risk Factors Associated with Weight Gain during Treatment with Dupilumab among Patients with Moderate to Severe Atopic Dermatitis

中重度特应性皮炎患者接受度普利尤单抗治疗期间体重增加的相关风险因素

Tayefi, Mahsa; Svedbom, Axel; Ivert, Lina; Lundqvist, Maria; Ruas, Jorge; Bradley, Maria; Johansson, Emma

Serum Beta-Defensin-2 is a biomarker for psoriasis but not subclinical atherosclerosis: Role of IL17a, PI-3 kinase and Rac1

血清 β-防御素-2 是银屑病的生物标志物,但不是亚临床动脉粥样硬化的生物标志物:IL17a、PI-3 激酶和 Rac1 的作用

C J Pantoja, H Li, J Rodante, A Keel, A V Sorokin, A Svedbom, H L Teague, M Stahle, N N Mehta, M P Playford

Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by Indication

识别炎症性关节炎患者一线皮下注射TNF抑制剂持续治疗的预测因素:基于适应症的决策树分析

Dalén, Johan; Svedbom, Axel; Hernlund, Emma; Olofsson, Tor; Black, Christopher M

Interleukin-17 and - 23 Inhibitors Associated with Direct Effects on Depressive Symptoms in Psoriasis: Results from a Register Study

白细胞介素-17和-23抑制剂与银屑病抑郁症状的直接疗效相关:一项注册研究的结果

Svedbom, Axel; Ståhle, Mona

Establishment and Utility of SwedAD: A Nationwide Swedish Registry for Patients with Atopic Dermatitis Receiving Systemic Pharmacotherapy

SwedAD的建立和应用:一个覆盖瑞典全国的接受全身药物治疗的特应性皮炎患者登记系统

Alsterholm, Mikael; Svedbom, Axel; Anderson, Chris D; Holm Sommar, Lena; Ivert, Lina U; Josefson, Anna; Von Kobyletzki, Laura; Lindberg, Magnus; Lundeberg, Lena; Lundqvist, Maria; Nylander, Elisabet; Sandström Falk, MariHelen; Shayesteh, Alexander; Sigurdardottir, Gunnthorunn; Sonesson, Andreas; Svensson, Åke; Virtanen, Marie; Vrang, Sophie; Wahlgren, Carl-Fredrik; Bradley, Maria; Johansson, Emma K